The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Outcomes of Bacteremia in Patients with Cancer and Neutropenia: Observations from Two Decades of Epidemiological and Clinical Trials
Abstract
The prognostic significance of major organ and tissue infection was examined in 909 episodes of bacteremia that were selected from 10 consecutive, randomized clinical trials of antibiotic therapy for infection in patients with cancer and neutropenia. Extensive tissue infection significantly compromised response to initial therapy (38% vs. 74%; P < .0001), ultimate outcome of infection (73% vs. 94%; P < .0001), median time to normalization of temperature (5.3 days vs. 2.5 days; P < .0001), and survival (P < .0001). Other poor prognostic factors revealed by logistic regression included shock (P < .0001) and bacteremia caused by Pseudomonas species (P = .03), Clostridium species (P = .006), or a pathogen resistant to antibiotics used for initial therapy (P < .0001). Recovery of the granulocyte count predicted a superior response (P < .0001). Although the overall mortality rate was not significantly increased when patients with bacteremia due to gram-negative organisms initially received monotherapy or when patients with bacteremia due to gram-positive organisms received delayed vancomycin therapy, these strategies increased the duration of therapy by 25%. Patients with bacteremia due to alpha-hemolytic streptococcus died more often when vancomycin was not included in the initial empirical regimen (P = .004). Because of the prognostic significance of extensive tissue or major organ infection, this factor should be considered in decisions concerning modification of therapy and use of colony-stimulating factors. The cost-effectiveness of initial monotherapy and delayed vancomycin therapy remains to be demonstrated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotic Susceptibility Testing by a Standardized Single Disk Method
Bauer, A. W., Kirby, W. M. M., Sherris, J. C., & Turck, M. (1966) · American Journal of Clinical Pathology · doi:10.1093/ajcp/45.4_ts.493 · Cited by 18,523
MANUAL FOR THE IDENTIFICATION OF MEDICAL BACTERIA
Neter, E. (1965) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.55.12.2047-a · Cited by 2,583
Pneumococcal Bacteremia with Especial Reference to Bacteremic Pneumococcal Pneumonia
AUSTRIAN, R., & GOLD, J. (1964) · Annals of Internal Medicine · doi:10.7326/0003-4819-60-5-759 · Cited by 923
Emergence of Vancomycin Resistance in Coagulase-Negative Staphylococci
Schwalbe, R. S., Stapleton, J. T., & Gilligan, P. H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704093161507 · Cited by 584
Emergence of Enterococcus as a Significant Pathogen
Moellering, R. C. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.6.1173 · Cited by 578
Elting, L. S., Bodey, G. P., & Keefe, B. H. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.6.1201 · Cited by 377
Self-citationGuidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever--Reply
Hughes, W. T., Armstrong, D., Bodey, G. P., Feld, R., Mandell, G. L., Meyers, J. D., Pizzo, P. A., Schimpff, S. C., Shenep, J. L., Wade, J. C., et al. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/163.1.202 · Cited by 319
Self-citationPizzo, P. A., Armstrong, D., Bodey, G., Pauw, B. D., Feld, R., Glauser, M., Gaya, H., Karp, J., Klastersky, J., Todeschini, G., et al. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/161.3.397 · Cited by 277
Self-citationFreifeld, A. G., Walsh, T., Marshall, D., Gress, J., Steinberg, S. M., Hathorn, J., Rubin, M., Jarosinski, P., Gill, V, & Young, R. C. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.1.165 · Cited by 211
Elting, L. S., & Bodey, G. P. (1990) · Medicine · doi:10.1097/00005792-199009000-00003 · Cited by 198
Self-citationKarp, J. E., Dick, J. D., Angelopulos, C., Charache, P., Green, L., Burke, P. J., & Saral, R. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90257-3 · Cited by 186
A Three-Year Study of Positive Blood Cultures, with Emphasis on Prognosis
Roberts, F. J., Greere, I. W., & Coldman, A. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.1.34 · Cited by 186
Shenep, J. L., Hughes, W. T., Roberson, P. K., Blankenship, K. R., Baker, D. K., Meyer, W. H., Gigliotti, F., Sixbey, J. W., Santana, V. M., Feldman, S., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810203191604 · Cited by 168
Bacteremia and fungemia in patients with neoplastic disease
Whimbey, E. E., Kiehn, T. E., Brannon, P., Blevins, A., & Armstrong, D. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90007-6 · Cited by 137
Miller, P. J., & Wenzel, R. P. (1987) · The Journal of Infectious Diseases · doi:10.1093/infdis/156.3.471 · Cited by 127
Klastersky, J., Zinner, S. H., Calandra, T., Gaya, H., Glauser, M. P., Meunier, F., Rossi, M., Schimpff, S. C., Tattersall, M. H. N., & Viscoli, C. (1988) · PubMed · Cited by 119
Weight gain with breast cancer adjuvant treatment
Levine, E. G., Raczynski, J. M., & Carpenter, J. T. (1991) · Cancer · doi:10.1002/1097-0142(19910401)67:7<1928::aid-cncr2820670718>3.0.co;2-9 · Cited by 100
Anaissie, E. J., Vartivarian, S. E., Bodey, G. P., Legrand, C., Kantarjian, H. M., Abi-Said, D., Karl, C. L., & Vadhan‐Raj, S. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)90006-6 · Cited by 95
Self-citationPolymicrobial Bacteremia in the Late 1980s: Predictors of Outcome and Review of the Literature
Cooper, G. S., Havlir, D. S., Shlaes, D. M., & Salata, R. A. (1990) · Medicine · doi:10.1097/00005792-199003000-00005 · Cited by 73
Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients
Anaissie, E. J., Fainstein, V., Bodey, G. P., et al. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90140-4 · Cited by 66
Self-citationβ-Lactam regimens for the febrile neutropenic patient
Bodey, G. P., Fainstein, V., Elting, L. S., Anaissie, E. J., Rolston, K. V. I., Khardori, N. M., Kantarjian, H. M., Plager, C., Murphy, W. K., Holmes, F. A., et al. (1990) · Cancer · Cited by 50
Self-citationRAAD, I. I., Whimbey, E. E., Rolston, K. V., Abi-Said, D., Hachem, R. Y., Pandya, R. G., Ghaddar, H. M., Karl, C. L., & Bodey, G. P. (1996) · Cancer · Cited by 43
Self-citationEscherichia coli bacteremia in cancer patients
Bodey, G. P., Elting, L. S., Kassamali, H., & Lim, B. P. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90518-8 · Cited by 38
Self-citation
Cited by
Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir073 · Cited by 3,463
Self-citation2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
Hughes, W. T., Armstrong, D., Bodey, G. P., Bow, E. J., Brown, A. E., Calandra, T., Feld, R., Pizzo, P. A., Rolston, K. V. I., Shenep, J. L., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/339215 · Cited by 1,964
Self-citationKuderer, N. M., Dale, D. C., Crawford, J., & Lyman, G. H. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.8823 · Cited by 720
Freifeld, A. G., Bow, E. J., Sepkowitz, K. A., Boeckh, M. J., Ito, J. I., Mullen, C. A., Raad, I. I., Rolston, K. V., Young, J.-A. H., & Wingard, J. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq147 · Cited by 704
Self-citationWisplinghoff, H., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2003) · Clinical Infectious Diseases · doi:10.1086/374339 · Cited by 687
Metadata
- Authors
- Elting, L. S., Rubenstein, E. B., Rolston, K. V. I., & Bodey, G. P.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1997-08
- Volume
- 25
- Issue
- 2
- Pages
- 247-259
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2114886848
- Cited by
- 385
- References
- 23
- FWCI
- 3.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.